KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.58 $2.30 Friday, 26th Apr 2024 CTMX stock ended at $1.59. This is 0.625% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 3.77% from a day low at $1.59 to a day high of $1.65.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Oct 29, 2021 $5.94 $5.95 $5.79 $5.93 819 881
Oct 28, 2021 $5.54 $5.98 $5.46 $5.94 981 389
Oct 27, 2021 $5.33 $5.53 $5.33 $5.48 802 117
Oct 26, 2021 $5.35 $5.45 $5.26 $5.40 357 340
Oct 25, 2021 $5.34 $5.36 $5.18 $5.33 519 223
Oct 22, 2021 $5.11 $5.36 $4.94 $5.34 838 044
Oct 21, 2021 $5.05 $5.16 $5.05 $5.11 215 512
Oct 20, 2021 $5.03 $5.08 $4.98 $5.07 253 646
Oct 19, 2021 $5.01 $5.07 $4.91 $5.04 243 035
Oct 18, 2021 $5.15 $5.18 $4.97 $5.00 439 767
Oct 15, 2021 $5.25 $5.25 $5.10 $5.14 376 590
Oct 14, 2021 $5.21 $5.27 $5.14 $5.19 314 185
Oct 13, 2021 $5.12 $5.22 $5.08 $5.15 379 875
Oct 12, 2021 $4.97 $5.09 $4.94 $5.09 366 210
Oct 11, 2021 $4.87 $5.05 $4.82 $4.98 172 759
Oct 08, 2021 $4.86 $4.89 $4.79 $4.83 335 106
Oct 07, 2021 $4.91 $4.99 $4.85 $4.87 194 488
Oct 06, 2021 $4.88 $4.91 $4.76 $4.89 327 940
Oct 05, 2021 $5.05 $5.11 $4.88 $4.89 231 907
Oct 04, 2021 $5.08 $5.13 $4.96 $5.00 400 651
Oct 01, 2021 $5.08 $5.15 $4.96 $5.11 283 704
Sep 30, 2021 $4.99 $5.15 $4.98 $5.09 341 391
Sep 29, 2021 $5.21 $5.24 $4.91 $4.93 437 955
Sep 28, 2021 $5.37 $5.38 $5.14 $5.16 435 762
Sep 27, 2021 $5.25 $5.45 $5.22 $5.41 340 942
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT